EUVIMEDEUVIMED entdecken
FallberichtLeitlinie

A Case of Clostridioides difficile : Update on Practice Guidelines

Megan R Undeberg, Dana R Bowers, Kimberly C McKeirnan

The Senior Care Pharmacist · 2023

DOI: 10.4140/tcp.n.2023.370 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Senior Care Pharmacist, 2023. Verfasst von Megan R Undeberg und 2 weiteren Autor:innen. Beteiligte Einrichtung: 1Washington State University College of Pharmacy and Pharmaceutical Sciences, Pharmacotherapy Department, Spokane, Washington. Hauptthemen laut MEDLINE: Clostridioides, Clostridioides difficile. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This report describes a case of recurrent Clostridioides difficile infection (CDI) and illustrates that pharmacist’s role in selecting appropriate treatment. The report discusses CDI risk factors and reviews the guidelines for the pharmacological management of CDI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClostridioidesClostridioides difficileHumans

Autor:innen und Institutionen

  • 1Washington State University College of Pharmacy and Pharmaceutical Sciences, Pharmacotherapy Department, Spokane, Washington.
  • 2Washington State University College of Pharmacy and Pharmaceutical Sciences, Pharmacotherapy Department, Yakima, Washington.

Zitieren

APA

Undeberg, M. R., Bowers, D. R., & McKeirnan, K. C. (2023). A Case of Clostridioides difficile : Update on Practice Guidelines. The Senior Care Pharmacist. https://doi.org/10.4140/tcp.n.2023.370

Vancouver

Undeberg MR, Bowers DR, McKeirnan KC. A Case of Clostridioides difficile : Update on Practice Guidelines. The Senior Care Pharmacist. 2023. doi:10.4140/tcp.n.2023.370

BibTeX
@article{Undeberg2023,
  author = {Undeberg, Megan R and Bowers, Dana R and McKeirnan, Kimberly C},
  title = {A Case of Clostridioides difficile : Update on Practice Guidelines},
  journal = {The Senior Care Pharmacist},
  year = {2023},
  doi = {10.4140/tcp.n.2023.370}
}
Kostenlos starten →